Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas C Wolf

Showing results (81-90 of 130) with videos related to

Pageof 13
Sort By:
Toxicologic Pathology|May 10, 2008
Gene profiling in the livers of wild-type and PPARalpha-null mice exposed to perfluorooctanoic acidMitchell B Rosen, Barbara D Abbott, Douglas C Wolf, et al.
Archives of Toxicology|September 24, 2021
The codification of hazard and its impact on the hazard versus risk controversyJohn E Doe, Alan R Boobis, Samuel M Cohen, et al.
Regulatory Toxicology and Pharmacology : RTP|February 19, 2017
Response to Loomis et al Comment on Boobis et alAlan R Boobis, Samuel M Cohen, Vicki L Dellarco, et al.
Archives of Toxicology|June 14, 2022
A new approach to the classification of carcinogenicityJohn E Doe, Alan R Boobis, Samuel M Cohen, et al.
Toxicology and Applied Pharmacology|February 25, 2021
Integration of paraquat pharmacokinetic data across species using PBPK modellingJerry L Campbell, Kim Z Travis, Harvey J Clewell, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 11, 2010
Certolizumab pegol in patients with moderate to severe Crohn's disease and secondary failure to infliximabWilliam J Sandborn, Maria T Abreu, Geert D'Haens, et al.
Regulatory Toxicology and Pharmacology : RTP|January 12, 2019
Chemical carcinogenicity revisited 3: Risk assessment of carcinogenic potential based on the current state of knowledge of carcinogenesis in humansSamuel M Cohen, Alan R Boobis, Vicki L Dellarco, et al.
Regulatory Toxicology and Pharmacology : RTP|January 12, 2019
Chemical carcinogenicity revisited 1: A unified theory of carcinogenicity based on contemporary knowledgeDouglas C Wolf, Samuel M Cohen, Alan R Boobis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2012
Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel diseaseUma Mahadevan, Douglas C Wolf, Marla Dubinsky, et al.
Regulatory Toxicology and Pharmacology : RTP|November 7, 2016
Classification schemes for carcinogenicity based on hazard-identification have become outmoded and serve neither science nor societyAlan R Boobis, Samuel M Cohen, Vicki L Dellarco, et al.
Pageof 13

Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Toxicologic Pathology|May 10, 2008
Gene profiling in the livers of wild-type and PPARalpha-null mice exposed to perfluorooctanoic acidMitchell B Rosen, Barbara D Abbott, Douglas C Wolf, et al.
Archives of Toxicology|September 24, 2021
The codification of hazard and its impact on the hazard versus risk controversyJohn E Doe, Alan R Boobis, Samuel M Cohen, et al.
Regulatory Toxicology and Pharmacology : RTP|February 19, 2017
Response to Loomis et al Comment on Boobis et alAlan R Boobis, Samuel M Cohen, Vicki L Dellarco, et al.
Archives of Toxicology|June 14, 2022
A new approach to the classification of carcinogenicityJohn E Doe, Alan R Boobis, Samuel M Cohen, et al.
Toxicology and Applied Pharmacology|February 25, 2021
Integration of paraquat pharmacokinetic data across species using PBPK modellingJerry L Campbell, Kim Z Travis, Harvey J Clewell, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 11, 2010
Certolizumab pegol in patients with moderate to severe Crohn's disease and secondary failure to infliximabWilliam J Sandborn, Maria T Abreu, Geert D'Haens, et al.
Regulatory Toxicology and Pharmacology : RTP|January 12, 2019
Chemical carcinogenicity revisited 3: Risk assessment of carcinogenic potential based on the current state of knowledge of carcinogenesis in humansSamuel M Cohen, Alan R Boobis, Vicki L Dellarco, et al.
Regulatory Toxicology and Pharmacology : RTP|January 12, 2019
Chemical carcinogenicity revisited 1: A unified theory of carcinogenicity based on contemporary knowledgeDouglas C Wolf, Samuel M Cohen, Alan R Boobis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2012
Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel diseaseUma Mahadevan, Douglas C Wolf, Marla Dubinsky, et al.
Regulatory Toxicology and Pharmacology : RTP|November 7, 2016
Classification schemes for carcinogenicity based on hazard-identification have become outmoded and serve neither science nor societyAlan R Boobis, Samuel M Cohen, Vicki L Dellarco, et al.
Pageof 13